創勝集團 - 全整合型國際化生物制藥公司

創勝集團, 生物藥, 抗體, 藥物研發

創勝集團 - 全整合型國際化生物制藥公司

加入我們 聯繫我們

媒體報道

媒體報道

Industrialization of Highly Intensified Connected/Continuous Biomanufacturing Platform (HiCB) to Address Patient and Business Needs

2022 年 11 月 25 日

- Integrate HiCB and novel facility design to provide flexibility, speed, high quality at low cost  

- Platform designed to simplified PD while minimizing tech transfer, scale up and manufacturing risks

- Showcase implementation strategy and plan